Clinical Trial Update: Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) [Phase 2]

View source ↗

Summary

Phase 2 trial update from PREVAIL on Ebola vaccines conducted in Liberia; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Virus | Phase 2 | Status: COMPLETED | Results posted: 2017-08-01